ArticleHeliyon2024

Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP/PS1 mouse model of Alzheimer's disease.

Laura Martínez-Drudis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.